![Anthony D. Piscopio](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anthony D. Piscopio
Founder at OnKure, Inc.
Anthony D. Piscopio active positions
Companies | Position | Start | End |
---|---|---|---|
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Chief Tech/Sci/R&D Officer | - | - |
Founder | 01/04/2011 | - | |
Director/Board Member | 01/04/2011 | - | |
Chief Executive Officer | 01/04/2011 | - | |
President | - | - | |
Core Brewing & Distilling Co. LLC
![]() Core Brewing & Distilling Co. LLC Beverages: AlcoholicConsumer Non-Durables Core Brewing & Distilling Co. LLC engages in the brewing of beer. It offers year-round, limited-release, and taproom beers. The company was founded by Jesse Core in September 2010 and is headquartered in Springdale, AK. | Director/Board Member | - | - |
Career history of Anthony D. Piscopio
Former positions of Anthony D. Piscopio
Companies | Position | Start | End |
---|---|---|---|
ARRAY TECHNOLOGIES, INC. | Founder | 01/01/1998 | 01/01/2006 |
Corporate Officer/Principal | 01/01/2006 | 01/01/2006 | |
PFIZER, INC. | Corporate Officer/Principal | - | - |
Amgen BV
![]() Amgen BV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen BV is a Dutch biotech company that specializes in using living cells to create biologic medicines. The company has helped pioneer the biotech industry and are committed to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Amgen's medicines treat serious illnesses and typically address diseases with a limited number of treatment options. The company has a presence in approximately 100 countries and have reached millions of people with their products. Amgen has a robust pipeline focused on the pursuit of transformative medicines with large effects in serious diseases, using human genetic validation whenever possible to strengthen the evidence base for as many of their programs as possible. | Corporate Officer/Principal | - | - |
Chemizon, Inc.
![]() Chemizon, Inc. Pharmaceuticals: MajorHealth Technology Chemizon, Inc. engages in the provision of drug discovery services. The company was founded by Anthony D. Piscopio on January 18, 2005 and is headquartered in Seongnam, South Korea. | Chief Executive Officer | 28/07/2010 | - |
Chairman | 28/07/2010 | - | |
Founder | 28/07/2010 | - |
Training of Anthony D. Piscopio
University of Wisconsin | Doctorate Degree |
Statistics
International
United States | 6 |
South Korea | 2 |
Netherlands | 2 |
Operational
Founder | 3 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 6 |
Consumer Services | 2 |
Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 5 |
---|---|
Chemizon, Inc.
![]() Chemizon, Inc. Pharmaceuticals: MajorHealth Technology Chemizon, Inc. engages in the provision of drug discovery services. The company was founded by Anthony D. Piscopio on January 18, 2005 and is headquartered in Seongnam, South Korea. | Health Technology |
Amgen BV
![]() Amgen BV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen BV is a Dutch biotech company that specializes in using living cells to create biologic medicines. The company has helped pioneer the biotech industry and are committed to discovering, developing, manufacturing, and delivering innovative human therapeutics to patients suffering from serious illnesses. Amgen's medicines treat serious illnesses and typically address diseases with a limited number of treatment options. The company has a presence in approximately 100 countries and have reached millions of people with their products. Amgen has a robust pipeline focused on the pursuit of transformative medicines with large effects in serious diseases, using human genetic validation whenever possible to strengthen the evidence base for as many of their programs as possible. | Health Technology |
Array BioPharma, Inc.
![]() Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
OnKure, Inc.
![]() OnKure, Inc. BiotechnologyHealth Technology OnKure, Inc. engages in the discovery and development of epigenetic therapies for the treatment of cancer. It develops selective inhibitors of histone deacetylases in preclinical models of both hematological and solid tumor cancers. The company was founded by Xuedong Liu and Anthony D. Piscopio in April 2011 and is headquartered in Longmont, CO. | Health Technology |
Core Brewing & Distilling Co. LLC
![]() Core Brewing & Distilling Co. LLC Beverages: AlcoholicConsumer Non-Durables Core Brewing & Distilling Co. LLC engages in the brewing of beer. It offers year-round, limited-release, and taproom beers. The company was founded by Jesse Core in September 2010 and is headquartered in Springdale, AK. | Consumer Non-Durables |
- Stock Market
- Insiders
- Anthony D. Piscopio
- Experience